Relay Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
17.31 | 61.47 | -71.84% | -17.17 | -200.83% |
| P/S |
|
55.08 | 33.58 | 64.04% |
|
|
| P/BV |
|
1.87 | 4.79 | -60.95% |
|
|
| P/FCF |
|
-4.24 | 60.06 | -107.06% |
|
|
| Ev/Ebitda |
|
-3.46 | -17.26 | -79.95% |
|
|
| Ev/S |
|
51.55 | 22.49 | 129.25% |
|
|
| Ev/FCF |
|
-4.33 | 67.63 | -106.4% |
|
|
| E/P |
|
-0.2651 | 0.0168 | -1674.03% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1489.76 | -12.31 | 12006.97% | -5636.74 | -73.57% |
| ROE |
|
-45.47 | 9.39 | -584.22% |
|
|
| ROA |
|
-40.52 | 0.1519 | -26770.54% |
|
|
| ROIC |
|
-47.5 | 7.63 | -722.19% |
|
|
| ROS |
|
-1338.66 | -25.64 | 5120.85% |
|
|
| ROCE |
|
-51.31 | 14.76 | -447.68% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1405 | -3.68 | -96.18% | -0.1351 | +3.96% |
| Nеt Debt/Ebitda |
|
0.2372 | -4.07 | -105.83% |
|
|
| Debt/Ratio |
|
0.0633 | 0.199 | -68.17% |
|
|
| Debt/Equity |
|
4.61 | 1.67 | 176.81% |
|
|
| Debt/Net Income |
|
-0.1563 | 10.34 | -101.51% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-69.11 | 76.2 | -190.7% | ||
| Growth impulse Ebitda in 5 years |
|
360.78 | 44.75 | 706.21% | ||
| Growth impulse Net Income in 5 years |
|
413.47 | -15.36 | -2791.86% | ||
| Growth impulse FCF in 5 years |
|
310.85 | -9.39 | -3410.44% | ||
| Growth impulse EPS in 5 years |
|
-85.54 | -84.03 | 1.8% |
IP Score
3.82/10
